Mylan Again Defeats Allergan's Efforts to Deny Patients Access to More Affordable Medicine

HERTFORDSHIRE, England and PITTSBURGH, July 20, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. Patent Trial and Appeal Board (PTAB), which found that...